
Arcadia Biosciences Inc
Arcadia Biosciences Inc (RKDA) is a small, niche agricultural biotechnology company focused on developing crop traits and seed technologies intended to improve nutrition, stress tolerance and yield potential. Its business historically relies on research, intellectual property and licensing agreements with seed companies and food producers rather than large-scale commercial farming operations of its own. For investors this means potential upside from successful trait adoption or licence deals, but also material risks: RKDA’s very small market capitalisation implies limited liquidity, and revenues can be irregular and dependent on partners, regulatory approvals and commodity cycles. Research-stage assets in agriculture face technical, regulatory and commercial hurdles. Before considering exposure, check the company’s recent filings, partnership announcements, cash position and patent positions. This summary is educational only and not personalised investment advice; small-cap biotech/agricultural stocks can be highly volatile and investors should be prepared for losses.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Arcadia Biosciences' stock with a target price of $12, indicating growth potential.
Financial Health
Arcadia Biosciences is generating steady revenue and cash flow but faces challenges in profitability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring RKDA
The Future Of Food: Investing In Sustainable Agriculture
Invest in companies pioneering sustainable farming practices and technologies to meet growing global food demand responsibly. This theme focuses on innovation in areas like precision agriculture, alternative proteins, and eco-friendly crop solutions.
Published: August 26, 2025
Explore BasketDrought-Resilient Agri Tech
These carefully selected companies are pioneering essential technologies that help agriculture thrive even as water becomes scarce. They represent the innovation frontier in feeding our growing world amid changing climate conditions, chosen by expert analysts for their potential and impact.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Licence & Royalties
Revenue often comes from licences and royalties on trait technologies; partnership deals can be value catalysts, though income may be uneven and uncertain.
Crop Trait Potential
Focus on traits such as stress tolerance and improved nutrition addresses global food challenges, but adoption depends on approvals, farmer uptake and market acceptance.
Small‑Cap Risks
A very small market capitalisation signals low liquidity and higher volatility; expect potential dilution and binary outcomes with research‑stage assets.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.